Brigit Biofarmaka Teknologi Tbk. vs Puri Global Sukses Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Puri Global Sukses Tbk. trades at Rp159 (market cap 162B, 9.39M 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. and Puri Global Sukses Tbk. are close in size by market cap, and Puri Global Sukses Tbk. is more actively traded (9.39M versus 324K). Which is the better fit depends on your goals.
| OBAT | PURI | |
|---|---|---|
Market Cap | 166.01B | 162B |
Volume | 324K | 9.39M |
Lot | 3.24K | 93.89K |
Turnover | 77.68M | 1.5B |
Average Price | 239.75 | 160.21 |
Value | 77.68M | 1.5B |
Indicative Equilibrium Price | 240 | 159 |
Indicative Equilibrium Volume | 1 | 1.44K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Puri Global Sukses Tbk (Company) was established in Batam based on notarial deed No. 19 dated January 20, 2016 of Bun Hai, S.H.,M.Kn. The Company has carried out its activitiescommercially in 2017.
Read more on PURI →